AbbVie Inc. (ABBV) income statement
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$286.01−6.81 (-2.33%)
Close on Nov 18, 2026Market cap $505.41BP/E 80.8Yield 2.33%
AbbVie Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 71.5%
- Operating margin
- 26.2%
- Net margin
- 9.8%
- Return on equity, FY2025
- 15367.3%
Financial strength
- Current ratio
- 0.81
- Debt to equity
- -11.93
- Debt to assets
- 52.4%
- Cash to current liabilities
- 15.8%
Valuation
- P/E ratio
- 80.8
- Price to sales
- 7.85
- Price to book
- –
- Dividend yield
- 2.33%
See a number that looks wrong?